Meloxicam tolerance in hypersensitivity to nonsteroidal anti-inflammatory drugs

Journal of Investigational Allergology and Clinical Immunology

Volumn 16, Issue 6, 2006, Pages 364-366

  Viñas Domingo, Marta ^a   Castillo Marchuet, M J ^a   Dordal Culla, M T ^a   Serra Joanpere, R ^a   Marti Guadano E ^a  

^a HOSPITAL DOS DE MAIG   (Spain)

Author keywords

Angioedema; Drug allergy; Meloxicam; Nonsteroidal anti inflammatory drugs; Tolerance; Urticaria

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; LACTOSE; LEUKOTRIENE A4; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROSTAGLANDIN D2;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; ASTHMA; CHRONIC URTICARIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RHINITIS; SINGLE BLIND PROCEDURE; URTICARIA;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CYCLOOXYGENASE 2 INHIBITORS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MALE; MIDDLE AGED; SINGLE-BLIND METHOD; THIAZINES; THIAZOLES;

EID: 33845611426     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Senna G, Bilo MB, Antonicelli L, Schiappoli M, Crivellaro MA, Bonadona P, Dama AR. Tolerability of three selective cyclo-oxigenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients. Allerg Immunol (Paris). 2004; 36(6):215-88.
2. Bavbek S, Celik G, Ozer F, Mungan D, Misirligil Z. Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam and rofecoxib. J Asthma. 2004;41(1):67-75.
3. Nettis E, Di Paola R, Ferrannini A, Tursi A. Meloxicam in hypersensitivity to NSAIDs Allergy. 2001;56(8):803-4.
4. Quarantino D, Romano A, Di Fonso M, Papa G, Perrone MR, D'Ambrosio FP, Venuti A. Tolerability of meloxicam in patients with histories of adverse reactions to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol. 2000;84:613-7.
5. Kosnik M, Music E, Matjaz F, Suskovic S. Relative safety to meloxicam in NSAID-intolerant patients. Allergy. 1998;53:1231-3.
6. Karakaya G, Fuat A. Safety of nimesulide, meloxicam and rofecoxib as alternatives analgesics. Allergol Immunopathol. 2000;28:319-21.
7. Zeitz HJ. Bronchial asthma, nasal polyps and aspirin sensitivity: Samter's syndrome. Clin Chest Med. 1988;9:567-76.
8. Settipane GA. Aspirin sensitivity and allergy. Biomed Pharmacother. 1988;42:493-8.
9. Kalyoncu AF, Karakaya G, Sahin AA, Baris YI. Occurrence of allergic conditions in asthmatics with analgesic intolerance. Allergy. 1999;54:428-35.
10. Mastalerz L, Setkowicz M, Sanak M, Szczeklik A. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol. 2004;113:771-5.
11. Mastalerz L, Setkowicz M, Sanak M, Rybarczyk H, Szczeklik A. Familial aggregation of aspirin-induced urticaria and leukotriene C4 synthase allelic variant. Br J Dermatol. 2006,154:256-60.
12. Szczeklik A, Nizankowska E, Bochenek G, Nargraba K, Mejza F, Swierczynska M. Safety of a specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy. 2001;31:219-25.
13. Mukherjee D, Nissen S, Topol EJ. Risk of cardio vascular events associated with selective COX-2 inhibitors. JAMA. 2001;286:954-9.
14. Topol EJ, Falk GW. A coxib a day won't keep the doctor away. Lancet 2004;364:639-40.
15. Bogaty P, Brophy JM, Noel M, Boyer L, Simard S, Bertrand F, Dagenais GR,. Impact of prolonged cyclo-oxigenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein. A randomized placebo-controlled study. Circulation. 2004;110:934-9.